WebBioAgency AG is a venture capital firm specializing in investments in startup and early stage. It prefers to invest in life science and biotech companies based in Germany or maximum of one and half hour flight time from Hamburg. The firm typically invests up to €1.5 million ($1.91 million) in series A and B financing. The firm can also invest along with … WebBioAgency AG owns a research programme, named NLX Target, which was developing therapeutics for the treatment of infectious and parasitic diseases. This Research programme: anti-infectives - BioAgency Next Previous Table of Contents At a glance Development Overview ...
ANACOR PHARMACEUTICALS INC innovation strategy - GoodIP
WebBioAgency AG is the private entrepreneurial catalyst for new life science companies in Germany. Use the CB Insights Platform to explore BioAgency's full profile. BioAgency Portfolio Investments, BioAgency Funds, BioAgency Exits WebThe participation, support, development and exploitation of projects or companies in whole or in part, primarily in the field of life sciences, especially in the fields of medicine, … scaredy cat films benchmark viewer
Fredericamycin A - AdisInsight
WebWe develop and manufacture innovative Bio-nutritional and Biological products that are effective in all agriculture production systems. WebBioAgency AG is a venture capital firm specializing in investments in startup and early stage. It prefers to invest in life science and biotech companies based in Germany or maximum of one and half hour flight time from Hamburg. The firm typically invests up to €1.5 million ($1.91 million) in series A and B financing. The firm can also invest ... http://reports.morphosys.com/2008/company/supervisory-board-morphosys-ag rugby town planning